The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
Go back to The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.31 +0.18 (3.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $7.47 | |||
| Open | $5.13 | 52 Week Low | $7.47 | |||
| Day High | $5.38 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $0.00 | |||
| Volume | 1,251,622 | |||||
| (NASDAQ: TOIIW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 22,000 | |||||
